Martin Shkreli, the 32-year-old Turing Pharmaceutical CEO who this week jacked up the price on a life-saving drug by an astounding 5,000 percent, apparently doesn’t have the stomach for his own racket: he announced Tuesday night he’ll decrease the price of the drug in the face of intense public scrutiny.